Thermo Fisher Scientific reported third-quarter revenue of $12.14 billion, up 9% year over year, with GAAP operating income of $2.263 billion, up ...

Illumina (ILMN) and Thermo Fisher Scientific (TMO) both sell to drug developers and the labs that test patients, but they ...

Citi analyst Patrick Donnelly raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $800.00 (from $685.00) while maintaining a Buy rating.

Thermo Fisher Scientific Inc. reported third-quarter 2026 results on October 21, 2026, with revenue up 9 percent to USD 12.14 ...

Thermo Fisher Logs Higher 3Q Profit, Revenue DJ Oct. 21 Thermo Fisher Scientific's Fiscal Q3 Adjusted Earnings, Revenue Increase MT Oct. 21 Earnings Flash (TMO) Thermo Fisher Scientific Inc. Reports ...

The Swedish buyout firm is paying cash for the testing-kit maker that slipped out of Thermo Fisher's grip during the pandemic ...

Thermo Fisher Scientific just reported Q3 2026 numbers that lit up the income statement while the share price barely shrugged ...

Thermo Fisher Scientific delivered strong Q3 results, with 6% organic growth, EPS and sales beats, and raised full-year ...

Thermo Fisher stock fell early Wednesday as its miss in life sciences overshadowed an otherwise solid third-quarter report.

Thermo Fisher Scientific Inc. reported its financial results for the third quarter ended September 26, 2026. Revenue for the quarter grew 9% to $12.14 billion, compared with $11.12 billion in the ...

Thermo Fisher Scientific reported third-quarter adjusted earnings of $6.68 per share on Wednesday, exceeding the $6.40 analyst estimate. Quarterly sales increas ...

Thanks to solid third quarter results, Thermo Fisher Scientific told analysts on an earnings call Wednesday morning that it raised its 2026 outlook. The company, which has facilities in Upper Saucon, ...